Equitable Trust’s MetLife MET Stock Holding History

Equitable Trust’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,137	Closed	-$257K	–	477
2024 Q4	$257K	Hold	3,137	–	–	0.01%	434
2024 Q3	$259K	Hold	3,137	–	–	0.02%	408
2024 Q2	$220K	Buy	3,137 +42	+1%	+$3K	0.02%	417
2024 Q1	$229K	Buy	+3,095	New	+$216K	0.02%	405

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Equitable Trust's MET Position: Q1 2025 in Review

Equitable Trust sold out of MetLife (MET) in Q1 2025, closing a stake of 3,137 shares — an estimated $257K sold.

Equitable Trust first reported a position in MET in Q1 2024 and held it in 4 quarters. The position peaked at $259K in Q3 2024. 1,411 funds tracked by Wall St. Rank hold MET as of Q1 2025.

Equitable Trust reported no remaining MetLife position as of Q1 2025 after selling out during the quarter.
Equitable Trust sold 3,137 MetLife shares in Q1 2025, an estimated $257K.
Equitable Trust first reported a position in MetLife in Q1 2024 and held it in 4 quarters.
Equitable Trust's MetLife position peaked at $259K in Q3 2024.
1,411 funds tracked by Wall St. Rank held MetLife as of Q1 2025.

Based on Equitable Trust's 13F filing for Q1 2025, filed 25 Apr 2025.